Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 21, 2022
Patent Application Number
16426001
Date Filed
May 30, 2019
Patent Citations
Patent Primary Examiner
CPC Code
The present invention provides a human PD-1 antibody, an antigen-binding fragment thereof, and medical use thereof, and further provides a chimeric antibody and humanized antibodies comprising a complementarity-determining region (CDR) of the antibody, a pharmaceutical composition comprising the human PD-1 antibody and the antigen-binding fragment thereof, and use of the antibody in preparing medicines for treating diseases or disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.